procarbazine/thalidomide

Cyclin-dependent kinase 9 (CDK9), an important regulator of transcriptional elongation, is a promising target for cancer therapy… Expand

Multiple myeloma (MM) accounts for 1% of all types of cancer and for 2% of all cancer deaths. These numbers are approximately 13… Expand

INTRODUCTION hemoglobinopathies constitute a major health problem worldwide. These disorders are characterized by a clinical and… Expand

The IFM 99-06 study (Oct 6, p 1209) showed that the combination of melphalan, prednisone, and thal idomide (MPT) was better than… Expand

In a recent study, it was reported that thalidomide may suppress mucosal, cutaneous and articular manifestations in the major i… Expand

The palliation of patients with megaesophagus secondary to achalasia of the cardia presents significant challenges to the surgeon… Expand

Sight threatening changes in the retina are a well-recognized complication of sickle cell disease (SCD). However they usually… Expand

The purpose of this study was to ascertain whether thalassemia heterozygotes (α thal) who have sickle cell anemia (SCA) suffer… Expand

La thalidomide, administree a 6 hommes volontaires sains, entraine une diminution du rapport cellules T. auxiliaires/cellules T… Expand

Thalidomide treatment of patients suffering from leprosy reaction (LR ) was introduced in 1964 (3). This thcrapy has a striking… Expand